Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal 1 receptor 110 pseudogene (VN1R110P) is classified as a pseudogene in humans and is part of the vomeronasal 1 receptor (V1R) gene family, which in other species encodes G protein-coupled receptors involved in pheromone detection[7][9][13]. However, in humans, VN1R110P does not encode a functional protein and does not participate in signal transduction or pheromone sensing[3][7][12]. There are no known drug interactions, mechanisms of action, biomarker applications, or safety concerns relevant to this pseudogene. Its biological and clinical significance appears to be limited to its status as a non-coding genomic element; it is not considered a therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal 1 receptor 110 pseudogene (VN1R110P).